Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems.

scientific article

Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems. is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1016/S0378-5173(00)00335-5
P8608Fatcat IDrelease_b7y2sqk6xrak5kgshjnepnsgtu
P698PubMed publication ID10704788

P50authorIan George TuckerQ59663127
P2093author name stringN M Davies
D C Bibby
P2860cites workInvestigations into the structure and composition of beta-cyclodextrin/poly(acrylic acid) microspheres.Q30578261
Thermodynamics of hydrogen bond and hydrophobic interactions in cyclodextrin complexesQ34040822
Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluationQ34417057
Mirror images: the analysis of pharmaceutical enantiomersQ35536298
1H NMR relaxation study of a chitosan-cyclodextrin networkQ36868149
Poly(acrylic acid) microspheres containing beta-cyclodextrin: loading and in vitro release of two dyes.Q38320077
Biodegradable microspheres in drug deliveryQ38565057
Cyclodextrins: their future in drug formulation and deliveryQ40895926
Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilizationQ41192883
Pharmaceutical applications of cyclodextrins. 2. In vivo drug deliveryQ41219657
Cyclodextrin derivatives in pharmaceuticsQ41720751
Use of 'soluble lipids' for biochemical processes: linoleic acid-cyclodextrin inclusion complexes in aqueous solutionsQ42826491
Formation and in-vitro evaluation of theophylline-loaded poly(methyl methacrylate) microspheresQ44164984
Drug diffusion and binding in ionizable interpenetrating networks from poly(vinyl alcohol) and poly(acrylic acid).Q47702245
In-vivo and In-vitro Correlation for Delayed-release Behaviour of a Molsidomine/O-carboxymethyl-O-ethyl-β-cyclodextrin Complex in Gastric Acidity-controlled DogsQ51591361
Oxprenolol release from bioadhesive gelatin/poly(acrylic acid) microspheres.Q52261252
Kinetics of anhydride formation in xerogels of poly(acrylic acid).Q52298198
Drug release from hydrophilic matrices. 2. A mathematical model based on the polymer disentanglement concentration and the diffusion layer.Q52322062
Population characteristics of cyclodextrin complex stabilities in aqueous solution.Q52337807
New hydrogels based on carbohydrate and on carbohydrate-synthetic polymer networksQ60367536
The Conformational Behaviour of Complexes of Alpha-Cyclodextrin with P-Chlorophenol and P-Hydroxybenzoic Acid in Water as Studied by Molecular Dynamics SimulationsQ68221619
Adsorption of inorganic and organic ions to polycarbophil as a means of sustained-release dosage formulationQ68855404
Complexation of several drugs with water-soluble cyclodextrin polymerQ69054503
In-vitro evaluation of biphenylyl acetic acid-beta-cyclodextrin conjugates as colon-targeting prodrugs: drug release behaviour in rat biological mediaQ71299571
beta-cyclodextrin derivatives, SBE4-beta-CD and HP-beta-CD, increase the oral bioavailability of cinnarizine in beagle dogsQ71895513
Interactions between beta-cyclodextrin and insoluble glyceride monomolecular films at the argon/water interface: application to lipase kineticsQ72018930
Modification of the dissolution behaviour of a water-insoluble drug, naftazone, for zero-order release matrix preparationQ72730776
Formulation of triamcinolone acetonide pellets suitable for coating and colon targetingQ74534003
Colon-specific drug delivery based on a cyclodextrin prodrug: release behavior of biphenylylacetic acid from its cyclodextrin conjugates in rat intestinal tracts after oral administrationQ74602174
Preparation and characterization of beta-cyclodextrin and poly(acrylic acid) microspheresQ77320820
Effect of ion exchange resins on the drug release from matrix tabletsQ77784913
P433issue1-2
P407language of work or nameEnglishQ1860
P921main subjectdrug deliveryQ1392806
P304page(s)1-11
P577publication date2000-03-01
P1433published inInternational Journal of PharmaceuticsQ6051539
P1476titleMechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems
P478volume197

Reverse relations

cites work (P2860)
Q58599492Active Food Packaging Coatings Based on Hybrid Electrospun Gliadin Nanofibers Containing Ferulic Acid/Hydroxypropyl-Beta-Cyclodextrin Inclusion Complexes
Q36548827Advances and potential applications of chitosan derivatives as mucoadhesive biomaterials in modern drug delivery.
Q29543246Affinity‐Based Drug Delivery
Q35555896Biotechnological applications of cyclodextrins
Q42917803Bone implants modified with cyclodextrin: Study of drug release in bulk fluid and into agarose gel
Q43196665Carbopol-based gels for nasal delivery of progesterone
Q42219479Cellulose acetate phthalate microparticles containing Vibrio cholerae: steps toward an oral cholera vaccine
Q41988630Cellulose-based matrix microspheres of prednisolone inclusion complex: preparation and characterization
Q41359733Characterization of methyl-beta-cyclodextrin toxicity in NGF-differentiated PC12 cell death.
Q54212185Chlorhexidine Loaded Cyclodextrin Containing PMMA Nanogels as Antimicrobial Coating and Delivery Systems.
Q30651263Combined hydroxypropyl-beta-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir
Q57376812Controlled delivery of dexamethasone to the intestine from poly(vinyl alcohol)–poly(acrylic acid) microspheres containing drug-cyclodextrin complexes: influence of method of preparation of inclusion complex
Q90217428Controlled delivery of ibuprofen from poly(vinyl alcohol)-poly(ethylene glycol) interpenetrating polymeric network hydrogels
Q43854178Cross-linked beta-cyclodextrin microcapsules. II. Retarding effect on drug release through semi-permeable membranes.
Q54224153Current Options and Emerging Biomaterials for Periprosthetic Joint Infection.
Q58602517Cyclodextrin Controlled Release of Poorly Water-Soluble Drugs from Hydrogels
Q57378378Cyclodextrin modified hydrogels of PVP/PEG for sustained drug release
Q41843480Cyclodextrin-polysaccharide-based, in situ-gelled system for ocular antifungal delivery.
Q35138039Cyclodextrins in delivery systems: Applications
Q57374231Cyclodextrins in drug delivery systems
Q57171907Drug delivery therapies II
Q58749808Effect on Nail Structure and Transungual Permeability of the Ethanol and Poloxamer Ratio from Cyclodextrin-Soluble Polypseudorotaxanes Based Nail Lacquer
Q28299123Effects of different cyclodextrins on the morphology, loading and release properties of poly (DL-lactide-co-glycolide)-microparticles containing the hypnotic agent etizolam
Q43962321Encapsulation of antigenic extracts of Salmonella enterica serovar. Abortusovis into polymeric systems and efficacy as vaccines in mice.
Q44455424Evaluation of the antiulcerogenic activity of violacein and its modulation by the inclusion complexation with beta-cyclodextrin
Q33788978First principles insight into the alpha-glucan structures of starch: their synthesis, conformation, and hydration
Q39338573Hydrophilic versus hydrophobic porogens for engineering of poly(lactide-co-glycolide) microparticles containing risedronate sodium
Q94674592In Vitro Release of 5-Fluorouracil and Methotrexate from Different Thermosensitive Chitosan Hydrogel Systems
Q37610470In vitro and in vivo evaluation of biologically synthesized silver nanoparticles for topical applications: effect of surface coating and loading into hydrogels.
Q36748033Incomplete protection against simian immunodeficiency virus vaginal transmission in rhesus macaques by a topical antiviral agent revealed by repeat challenges
Q89261408Incorporating β-cyclodextrin into collagen scaffolds to sequester growth factors and modulate mesenchymal stem cell activity
Q43717740Influence of betacyclodextrin on the release of poorly soluble drugs from inert and hydrophilic heterogeneous polymeric matrices
Q45953245Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
Q46704577Modified-release ointment with nitroglycerin β-cyclodextrin inclusion complex for treatment of anal fissures.
Q43569895Modulation of drug release from hydrogels by using cyclodextrins: the case of nicardipine/beta-cyclodextrin system in crosslinked polyethylenglycol.
Q39021288Monitoring model drug microencapsulation in PLGA scaffolds using X-ray powder diffraction.
Q45184671Multicomponent complexes of piroxicam with cyclodextrins and hydroxypropyl methylcellulose
Q46829291New cyclodextrin hydrogels cross-linked with diglycidylethers with a high drug loading and controlled release ability
Q46101248Novel cyclodextrin-based film formulation intended for buccal delivery of atenolol
Q36917923Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems.
Q39533415PLGA microparticles encapsulating prostaglandin E1-hydroxypropyl-β-cyclodextrin (PGE1-HPβCD) complex for the treatment of pulmonary arterial hypertension (PAH).
Q51496183Pharmacokinetic analysis and optimization of hydroxycamptothecin-loaded nanoparticles for liver targeting.
Q41989676Physicochemical properties and dissolution studies of dexamethasone acetate-beta-cyclodextrin inclusion complexes produced by different methods
Q40586018Preparation of Fluconazole β-Cyclodextrin Complex Ocuserts: In Vitro and In Vivo Evaluation
Q26739967Progress and Perspectives on HIV-1 microbicide development
Q44472524Pullulan-cyclodextrin microspheres. A chromatographic approach for the evaluation of the drug-cyclodextrin interactions and the determination of the drug release profiles
Q46738080Role of cellulose ether polymers on ibuprofen release from matrix tablets
Q42124356Role of hydroxypropyl-β-cyclodextrin on freeze-dried and gamma-irradiated PLGA and PLGA-PEG diblock copolymer nanospheres for ophthalmic flurbiprofen delivery
Q51488103Scalable single-step microfluidic production of single-core double emulsions with ultra-thin shells.
Q43090971Sorption of agrochemical model compounds by sorbent materials containing beta-cyclodextrin
Q42175771Thermosensitive Pluronic® hydrogel: prolonged injectable formulation for drug abuse
Q57343648β-Cyclodextrin hydrogel incorporating hydrophobically modified poly(N-isopropylacrylamide) for a temperature-dependent release
Q46762531β-Cyclodextrin- and adamantyl-substituted poly(acrylate) self-assembling aqueous networks designed for controlled complexation and release of small molecules

Search more.